HELP ADVANCE ITP RESEARCH!

HELP ADVANCE ITP RESEARCH!

Learn how your participation in the LUNA 3 study may help others with primary immune thrombocytopenia (ITP).

The LUNA 3 study is for adolescents and adults ages 10 and up (minimum age depends on country or study clinic location) with primary immune thrombocytopenia (ITP) for which standard medications are no longer working. The goal of the study is to see if the study medication can safely increase platelet counts and improve symptoms for people with ITP and how long the effects last.

PATIENTS WHO QUALIFY WILL RECEIVE AT NO COST:

• Access to study medication:
• About 1 out of every 3 patients will receive placebo (no active ingredients) in the first part of the study
• All patients will have the option to receive study medication in the second part of the study and in the study extension, if the study medication is working for them
• Study support and monitoring by a healthcare team
• Education about primary ITP

The study is running at Imperial, Southampton and Manchester.

For more information about the LUNA 3 study, send an email to Contact-US@sanofi.com or contact:

Dr Nichola Cooper/ Sobia Mustafa
Imperial College Healthcare NHS Trust
St Mary’s Hospital
Praed Street, London.
imperial.paediatricresearch@nhs.net
07979 687 976
020 3312 1449